American Fork, Utah, June 8, 2012 – Novarad’s NovaDose(™) solution that calculates cumulative patient, exam and modality ionizing radiation dose history now automatically reports the patient’s exam dose profile from directly into the NovaRIS diagnostic report without dictation or manual entry. This new convenience increases ease of use and saves time.
“We were first to fulfill the need for an integrated PACS, RIS and dose monitoring solution,” said Steve Fowler, product marketing director at Novarad Corporation. “Now with the automated reporting capability through NovaRIS, we are once again making it easier for providers to better manage patient treatments and mitigate risks.”
Novarad introduced radiation dose monitoring integrated with PACS in November and now with the addition of seamless integration with NovaRIS, facilities are assured the most comprehensive feature set, reporting flexibility and ease of use, while completely eliminating the need for a dedicated dose monitoring server at smaller facilities.The radiation dose monitoring engine, DoseMonitor(™), was developed by PHS Technologies Group.
NovaDose is available now for NovaPACS sites of all sizes, where ionizing radiation procedures are performed.
About PHS Technologies Group:
LLC PHS Technologies Group, LLC develops products for monitoring cumulative medical imaging radiation dose. The company is based in Scottsdale, Arizona; and is a wholly owned subsidiary of PACSHealth, LLC, the developer of PACSHealth(™) a PACS monitoring and audit tool currently installed at over 600 sites worldwide. DoseMonitor is ACR-DIR certified for data upload.
With more than 800 installations worldwide, Novarad is the healthcare community's trusted provider of radiology technologies. Novarad's full diagnostic suite of PACS, RIS, cardiology, orthopedic and mammography systems increase radiology efficiency and deliver unmatched value. Novarad products are consistently top rated, are easy to use and come with lifetime upgrades and the best support in the business. Images and reports are available anytime, anywhere via the full diagnostic viewer, iPad or any mobile device with web access. Novarad has been ISOcertified since 2006 and holds FDA 510(k) certification.
Steve Fowler, Novarad Corporation, email@example.com, 877-668-2723
Stephanie Miller, Novarad public relations, firstname.lastname@example.org, 801-487-4800 x141
Mike Battin, PHS Technologies Group, email@example.com, 877-877-1457 x802